All GSK articles – Page 5
-
Business
EU companies increasing R&D
Difficult economic climate has not diminished EU enthusiasm for R&D
-
News
GSK pledge on trials transparency
Pharma giant tackles critics by announcing that it will publish all clinical trials data regardless of the result
-
Business
GSK secures $3.6bn HGS deal
GlaxoSmithKline is set to buy Human Genome Sciences for $3.6 billion
-
Business
GSK drug shines in HIV trial
HIV–Aids drug candidate dolutegravir outperformed Atripla tablets in Phase III
-
Business$3bn GSK fine sets new industry record
The fine relates to off label marketing and is the largest payment of its kind ever made by a drug company
-
News€224 million EU antibiotics initiative launched
The project will bring together the pharmaceutical industry and academia, but some institutes have reservations
-
Business
GSK to build £350m factory in UK
GlaxoSmithKline (GSK) has announced £350 million plans to build its first new UK production plant for almost 40 years in Ulverston, Cumbria
-
News
GSK to build £350 million factory in UK
Tax breaks in the UK budget have prompted GSK to reaffirm its commitment
- Previous Page
- Page1
- Page2
- Page3
- Page4
- Page5
- Next Page